Literature DB >> 16798043

Identification of a cross-reactive HLA-DRB1*0301-restricted CD4 T cell response directed against cholesterol-binding cytolysins from two different pathogens.

Annette Paschen1, Mingxia Song, Simone Schenk, Jozef Janda, Xuan Duc Nguyen, Wolfram Osen, Dirk Schadendorf, Gernot Geginat.   

Abstract

Cholesterol-binding cytolysins constitute an evolutionarily conserved family of pore-forming proteins expressed by different gram-positive pathogens. Listeriolysin O, one well-characterized member of the cytolysin family, is also known to induce specific CD4 and CD8 T cell responses upon infection of mice with Listeria monocytogenes. Here we describe an HLA-DRB1*0301-restricted listeriolysin O-derived T cell epitope that is conserved among several members of the cytolysin family. An HLA-DRB1*0301-restricted CD4+ T cell line, established from spleen lymphocytes of L. monocytogenes-infected HLA-DRB1*0301-transgenic mice, cross-reacted with a homologous peptide from perfringolysin O, a cytolysin expressed by Clostridium perfringens. Ex vivo analysis of infected mice revealed an even broader cross-reaction of T cells with homologous peptides derived from perfringolysin O, streptolysin O, and cereolysin O. Interestingly, a cross-reactive memory CD4+ T cell response against the homologous peptides derived from listeriolysin O and perfringolysin O could also be detected in the blood from healthy HLA-DRB1*0301+ human donors. Remarkably, this response was even present in donors who did not exhibit a memory T cell reactivity against a second, non-conserved HLA-DRB1*0301-restricted LLO-derived CD4 T cell epitope, suggesting that cytolysin-producing bacteria other than L. monocytogenes can stimulate a cross-reactive cytolysin-specific immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798043     DOI: 10.1016/j.micinf.2006.03.010

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  3 in total

1.  Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.

Authors:  Holger Rüssmann; Klaus Panthel; Brigitte Köhn; Stefan Jellbauer; Sebastian E Winter; Sara Garbom; Hans Wolf-Watz; Sigrid Hoffmann; Silke Grauling-Halama; Gernot Geginat
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

2.  Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.

Authors:  Meredith L Leong; Johannes Hampl; Weiqun Liu; Shruti Mathur; Keith S Bahjat; William Luckett; Thomas W Dubensky; Dirk G Brockstedt
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

3.  Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes.

Authors:  Rupert L Mayer; Rein Verbeke; Caroline Asselman; Ilke Aernout; Adillah Gul; Denzel Eggermont; Katie Boucher; Fabien Thery; Teresa M Maia; Hans Demol; Ralf Gabriels; Lennart Martens; Christophe Bécavin; Stefaan C De Smedt; Bart Vandekerckhove; Ine Lentacker; Francis Impens
Journal:  Nat Commun       Date:  2022-10-14       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.